RATIONALLY DESIGNED COMBINATION CHEMOTHERAPY FOR THE TREATMENT OF PATIENTS WITH RECALCITRANT PSORIASIS

被引：6

作者：

ALPER, JC ^{[1
]}

WIEMANN, MC ^{[1
]}

RUECKL, FS ^{[1
]}

MCDONALD, CJ ^{[1
]}

CALABRESI, P ^{[1
]}

机构：

[1] BROWN UNIV,PROVIDENCE,RI 02912

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 1985年 / 13卷 / 04期

关键词：

D O I：

10.1016/S0190-9622(85)70198-3

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：567 / 577

页数：11

共 31 条

[1]

ALPER JC, 1982, CLIN RES, V30, P551

[2] UNSUCCESSFUL FLUOROURACIL TREATMENT OF PSORIASIS [J].

AUERBACH, R .

ARCHIVES OF DERMATOLOGY, 1974, 109 (01) :102-102

[3] UNSUCCESSFUL FLUOROURACIL TREATMENT OF RECALCITRANT PUSTULAR PSORIASIS [J].

BARRETT, JL ;

SAYERS, P .

ARCHIVES OF DERMATOLOGY, 1973, 108 (01) :135-135

[4] SCHEDULE-DEPENDENT CYTO-TOXICITY OF METHOTREXATE AND 5-FLUOROURACIL IN HUMAN-COLON AND BREAST-TUMOR CELL-LINES [J].

BENZ, C ;

SCHOENBERG, M ;

CHOTI, M ;

CADMAN, E .

JOURNAL OF CLINICAL INVESTIGATION, 1980, 66 (05) :1162-1165

[5]

BERTINO JR, 1977, CANCER RES, V37, P327

[6]

CALABROJONES PM, 1982, CANCER RES, V42, P4413

[7]

DEVITA VT, 1975, CANCER, V35, P98, DOI 10.1002/1097-0142(197501)35:1<98::AID-CNCR2820350115>3.0.CO

[8]

2-B

[9]

DILORENZO JA, 1975, CANCER RES, V34, P124

[10] RISKS AND BENEFITS OF THE TREATMENT OF PSORIASIS [J].

EPSTEIN, JH .

NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (15) :852-853

← 1 2 3 4 →